Routine dematerialisation compliance certificate for Q2 FY27

Compliance View source PDF Explain this filing

RPGLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.2%Reaction day

₹2895.00

prior close

₹2837.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.8%+0.5% vs market

Pharmaceuticals peers, median of 172sector-2.5%+0.2% vs sector

On the reaction day the stock moved 0.5 pts more than Nifty Microcap 250 and 0.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.5

15m

-1.5

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.2-2.8+0.5-2.5+0.2

Next day

-6.2-2.5-3.7-2.6-3.6

-1.6-1.7+0.0-2.5+0.9

-2.6-1.5-1.1-2.5-0.1

-2.4-0.8-1.6-2.5+0.1

-3.8-2.4-1.4-3.2-0.6

-1.6-3.4+1.8-4.4+2.8

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

RPG Life Sciences submitted a certificate from its Registrar and Transfer Agent, MUFG Intime India, under SEBI Regulation 74(5) for the quarter ended 30 September 2026. The RTA confirmed that securities received for dematerialisation were processed and listed on stock exchanges, and that physical certificates were cancelled with depositories recorded as owners within prescribed timelines. This is a standard regulatory compliance filing with no business or financial action involved.

Likely market impact

No impact on shareholders or stock price; routine procedural compliance with SEBI depositary regulations.